Cargando…
The Changing Landscape for New Drug Development: Medical Countermeasures (MCMs) as a Case Study
This chapter is comprised of materials adapted from previous publications authored by the Center for the Study of Drug Development at Tufts University School of Medicine (Tufts CSDD) over a ten-year period from 2010 through 2019. In addition, there are occasional infusions of updated commentary to “...
Autor principal: | Milne, Christopher-Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123580/ http://dx.doi.org/10.1007/978-3-030-16061-6_7 |
Ejemplares similares
-
Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic
por: Eren Vural, Ipek, et al.
Publicado: (2023) -
MCMs in Cancer: Prognostic Potential and Mechanisms
por: Yu, Si, et al.
Publicado: (2020) -
The Expression and Prognostic Roles of MCMs in Pancreatic Cancer
por: Peng, Yun-Peng, et al.
Publicado: (2016) -
The Alterations and Potential Roles of MCMs in Breast Cancer
por: Liu, Xinyu, et al.
Publicado: (2021) -
Routing in the third dimension: from VLSI chips to MCMs
por: Sherwani, N A, et al.
Publicado: (1995)